Insider Purchases: Inside the Buy

Tag: Dividends

Briefcase atop a skyline of REITs and infrastructure with a “BUY” ticket—signaling insider conviction, real-asset focus, and earnings leverage.

Cohen & Steers (CNS): Chairman Buys Millions—Time To Clip the Coupon or Clip Your Wings?

CNS shows mid-single-digit revenue growth, double-digit EPS growth, and a fresh $2.85M insider buy. Real-asset optionality, de-foamed multiple, TL;DR + FAQs.

 

Read entire article

Tags: Asset Management, Buy CNS Stock, CNS, Cohen & Steers, Dividends, ETFs, FUNanc1al, Infrastructure, Net Inflows, Preferreds, Real Assets, REITs, Valuation
Iridium-style LEO satellite beaming coverage to the whole globe with IoT and phone icons—signaling global reach, D2D potential, and investor focus on valuation.

CEO Bought Shares At Twice Today’s Price: Time To Buy Iridium Communications (IRDM)?

CEO bought at ~$37; shares now ~$19. We break down Iridium’s moat, IoT and PNT/D2D bets, valuation reset, and key risks—without the rocket emojis (ok, a few).

 

Read entire article

Tags: Buybacks, CEO Buys, CEO Conviction, CEO insider buying, CEO Stock Purchase, CEOBuyIn, CEOConfidence, Defense, Direct-to-Device, Dividend & Buybacks, Dividends, Dividends & Buybacks, DividendStocks, FUNanc1al, Funanc1al Edge, FUNanc1al Investing, IoT, IRDM, Iridium, LEO, PNT, Satellite, Telecom, Valuation
A playful digital illustration showund. Behind him, a rollercoaster-shaped stock chart rises, dips, and teases a reing a cartoon CEO holding a giant prescription bottle labeled

Viatris: The CEO Just Bought Shares… Should You Pop a Pill or Press "Buy"?

When a CEO personally buys over half a million dollars of stock, it’s time to pay attention. Viatris (VTRS) may be undervalued, with insider confidence, institutional backing, and a promising drug pipeline. But big losses and high debt mean it’s not risk-free. Is now the time to nibble?

Read entire article

Tags: CEO Buys, CEO insider buying, CEOBuyIn, CEOConfidence, Dividends, DividendStocks, Funanc1alHealth, Funanc1alPharma, Generics, HealthcareStocks, InsiderBuying, PharmaStocks, PipelineUpdate, stock dividends, StockBuybacks, ValueInvesting, Viatris, VTRS, VTRS Stock